{
"id":"mk19_a_id_q092",
"number":92,
"bookId":"id",
"correctAnswer":"E",
"title":"Question 92",
"stimulus":[
{
"type":"p",
"hlId":"91054a",
"class":"updated",
"children":[
"This question has been updated as a result of postpublication analysis and/or new data that are relevant to the question."
]
},
{
"type":"p",
"hlId":"8347de",
"children":[
"A 24-year-old woman is hospitalized for pelvic inflammatory disease. Her symptoms include abdominal discomfort and nausea with poor oral intake. She is sexually active with men but does not use condoms for all sexual encounters. Her only medication is an oral contraceptive."
]
},
{
"type":"p",
"hlId":"a46784",
"children":[
"On physical examination, temperature is 39.1 °C (102.3 °F), blood pressure is 110/60 mm Hg, and pulse rate is 115/min. Pelvic examination reveals mucopurulent discharge from the cervical os but no uterine or cervical motion tenderness, adnexal tenderness, or masses."
]
},
{
"type":"p",
"hlId":"01478a",
"children":[
"Laboratory studies show a ",
{
"type":"reference-range-link",
"referenceRange":"Leukocyte count",
"children":[
"leukocyte count"
]
},
" of 15,600/µL (15.6 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). A serum pregnancy test is negative."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"1054f1",
"children":[
"Which of the following is the most appropriate treatment?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Amoxicillin-clavulanate and doxycycline"
}
},
{
"letter":"B",
"text":{
"__html":"Cefoxitin and gentamicin"
}
},
{
"letter":"C",
"text":{
"__html":"Ceftriaxone and azithromycin"
}
},
{
"letter":"D",
"text":{
"__html":"Ceftriaxone and doxycycline"
}
},
{
"letter":"E",
"text":{
"__html":"Cefotetan and doxycycline"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"d52f58",
"children":[
"In women with pelvic inflammatory disease, signs of severe systemic toxicity or an inability to tolerate oral antibiotics, pregnancy, tubo-ovarian abscess, inability to exclude a surgical emergency, and failed outpatient antibiotic therapy are indications for hospitalization and parenteral therapy."
]
},
{
"type":"keypoint",
"hlId":"7f2df8",
"children":[
"Combination cefotetan or cefoxitin plus doxycycline or combination ceftriaxone plus doxycycline plus metronidazole are the preferred parenteral antibiotic regimens for patients hospitalized with pelvic inflammatory disease."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"7d6c3e",
"children":[
"Cefotetan and doxycycline are appropriate antibiotic management for women with pelvic inflammatory disease (PID) who require hospitalization (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option E"
]
},
"). Ceftriaxone and doxycycline plus metronidazole, or cefoxitin plus doxycycline are also CDC-recommended therapies. Signs of severe systemic toxicity or an inability to tolerate oral antibiotics, pregnancy, tubo-ovarian abscess, inability to exclude a surgical emergency, or failed outpatient antibiotic therapy are indications for hospitalization and parenteral therapy in women with PID. This patient has tachycardia and a high fever; additionally, her nausea raises the concern she may be unable to tolerate oral therapy, so hospitalization is indicated. Organisms implicated in PID include ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria gonorrhoeae"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Chlamydia trachomatis"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycoplasma genitalium"
]
},
", and other endogenous vaginal flora (particularly anaerobes); 15% of cases also include Enterobacteriaceae. Despite the polymicrobial nature of the infection, cervical discharge should be tested only for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"N. gonorrhoeae"
]
},
" and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"C. trachomatis"
]
},
" with nucleic acid amplification testing. FDA-approved testing for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"M. genitalium"
]
},
" is available, but routine testing for women with PID is not recommended. When the patient has clinically improved and can tolerate oral therapy, she can be discharged to complete a total of 14 days of therapy with oral doxycycline and metronidazole. At presentation, she should be screened for syphilis and HIV."
]
},
{
"type":"p",
"hlId":"4634dc",
"children":[
"The CDC sexually transmitted infection treatment guidelines do not recommend amoxicillin-clavulanate and doxycycline (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") for management of PID in any setting because it has not been studied; moreover, this patient requires a parenteral regimen because of her illness severity."
]
},
{
"type":"p",
"hlId":"065b4d",
"children":[
"Cefoxitin (or cefotetan) with doxycycline is a regimen recommended for inpatient treatment of PID; combining cefotetan or cefoxitin with gentamicin (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"), however, is not recommended. Doxycycline has excellent bioavailability; however, because this patient reported nausea, an all-parenteral initial regimen may be optimal. Parenteral doxycycline can cause significant infusion-site reactions (pain, erythema, swelling)."
]
},
{
"type":"p",
"hlId":"274e84",
"children":[
"Single-dose ceftriaxone with azithromycin (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") is no longer recommended for the treatment of uncomplicated cervicitis or urethritis. Single-dose ceftriaxone plus doxycycline (if chlamydial infection has not been excluded) is now first-line therapy for uncomplicated cervicitis or urethritis but is inadequate treatment for PID, which is a much more serious infection, even in an outpatient."
]
},
{
"type":"p",
"hlId":"a2b8eb",
"children":[
"Most women with PID can be managed as outpatients. A single dose of ceftriaxone followed by 14 days of doxycycline (with metronidazole) (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") is a recommended outpatient regimen for PID. This patient's nausea, poor oral intake, and signs of toxicity suggest the need for hospitalization and parenteral antibiotic therapy."
]
}
],
"relatedSection":"mk19_a_id_s9_5_2",
"objective":{
"__html":"Treat pelvic inflammatory disease in a patient requiring hospitalization."
},
"references":[
[
"Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70:1-187. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34292926",
"target":"_blank"
},
"children":[
"PMID: 34292926"
]
},
" doi:10.15585/mmwr.rr7004a1"
]
],
"hospitalist":true,
"hvc":false,
"peerComparison":{
"A":5,
"B":6,
"C":34,
"D":47,
"E":7
},
"hlIds":[
"91054a",
"8347de",
"a46784",
"01478a",
"1054f1",
"d52f58",
"7f2df8",
"7d6c3e",
"4634dc",
"065b4d",
"274e84",
"a2b8eb"
]
}